23 February, 2015.
The European Medicines Agency (EMA) has gathered representatives from European Union national authorities, software vendors, and other organizations to create a task force that will develop a strategy for the implementation of international standards for the identification of medicinal products (IDMP) in the EU. European pharmacovigilance legislation requires the use of common standards in the EU to identify and exchange information on medicines.
The International Organization for Standardization (ISO) developed IDMP standards to establish data elements, formats, and terminologies for the unique identification of drugs and the exchange of information on medicines, including pharmaceutical dosage forms, routes of administration, packaging, and active substances. The ISO standards were finalized in 2012 and implementation guidelines are expected to be published in 2016. According to EMA, the ISO standards will simplify the exchange of information between international regulatory authorities, therefore supporting the development of electronic health records and improving the safety monitoring of drugs.
Organizations interested in participating in the task force must express their interest to EMA by Mar. 6, 2015.
Source: European Medicines Agency
The Impact of Artificial Intelligence on the Creation of Medicines
October 24th 2024Najat Khan, chief R&D officer, chief commercial officer, Recursion, and Fred Hassan, director, Warburg Pincus, discuss how artificial intelligence can help reduce healthcare costs at the 20th Annual Young & Partners Pharmaceutical Executive Summit held at the Yale Club of New York.
Plan Ahead: Mastering Your AI Budget for 2025 Success
October 9th 2024Generative AI is just one part of the artificial intelligence and machine learning that is being used by life science organizations, emerging as a major area of interest and an area in which costs and ROI are still largely unknown.